Comparison Chart MacroGenics, Inc.

Stocks

MGNX

US5560991094

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 16:00:01 2026-06-26 EDT			5-day change	1st Jan Change
4.810 ^USD	+3.22%		+16.46%	+198.76%

06-22	MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment	MT
06-22	MacroGenics Receives Regulatory Milestone Payment From Sanofi Following FDA Accelerated Approval Of TZIELD To Delay Decline In Endogenous Insulin Production In Children Aged Eight To 17 Years With Stage 3 Type 1 Diabetes	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	MACROGENICS, INC.	Bio Therapeutic Drugs	+3.22%	+16.46%	+198.76%	+278.74%	-82.30%	306M